✦ LIBER ✦

Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody

✍ Scribed by YasserAbou Mourad; Ali Taher; Aref Chehal; Ali Shamseddine

Publisher: Springer
Year: 2004
Tongue: English
Weight: 118 KB
Volume: 83
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-003-0805-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment and re-treatment of

Successful treatment and re-treatment of resistant B-cell chronic lymphocytic leukemia with the monoclonal anti-CD 20 antibody rituximab

✍ M. Herold; A. Schulze; K. Härtwig; G. Anger 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 46 KB

Treatment of B-cell non-Hodgkin's lympho

Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab

✍ Stefano Sacchi; Massimo Federico; Giuseppe Dastoli; Claudia Fiorani; Giovanni Vi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Rituximab is a chimeric anti CD-20 monoclonal antibody containing human IgG1 kappa constant regions, with murine variable regions. The anti-lymphoma effects of Rituximab are probably due to complement and antibody-dependent cell-mediated cytotoxicity, and induction of apoptosis. Phase II trials have

Radioimmunotherapy of B-cell lymphoma wi

Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies

✍ R. O. Dillman 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 104 KB

Successful treatment of an Epstein-Barr

Successful treatment of an Epstein-Barr virus-associated B-cell lymphoproliferative disease in a child with acute lymphoblastic leukemia using an anti-CD20 monoclonal antibody

✍ Bernard, F. ;Sarran, N. ;Margueritte, G. ;Barneon, G. ;Astruc, J. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 2 views

Monoclonal Antibody Therapy for B-Cell L

Monoclonal Antibody Therapy for B-Cell Lymphoma: Clinical Trials of an Anti-CD20 Monoclonal Antibody for B-Cell Lymphoma in Japan

✍ Kensei Tobinai 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 276 KB

Successful Treatment With a Chimeric Ant

Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody

✍ Takahiro Maeda; Yasuaki Yamada; Masayuki Tawara; Reishi Yamasaki; Yuichi Yakata; 📂 Article 📅 2001 🏛 Carden Jennings Publishing 🌐 English ⚖ 188 KB